Cross Country Healthcare (CCRN) Tops Q1 EPS by 24c, Offers Q2 Guidance

Cross Country Healthcare (NASDAQ: CCRN) reported Q1 EPS of $0.58, $0.24 better than the analyst estimate of $0.34. Revenue for the quarter came in at $329.24 million versus the consensus estimate of $289.2 million.

GUIDANCE:

Cross Country Healthcare sees Q2 2021 EPS of $0.37-$0.42, versus the consensus of $0.15. Cross Country Healthcare sees Q2 2021 revenue of $300-310 million, versus the consensus of $237.3 million.

For earnings history and earnings-related data on Cross Country Healthcare (CCRN) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• Wintermar acquires full control of Fast Offshore Supply, adding 5 new CTVs